Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amesil is a specialized manufacturer of high-purity silicone products, including tubing, hose assemblies, and gaskets, primarily serving the pharmaceutical, biotechnology, and medical device industries. Founded in 1987 and later acquired by Saint-Gobain Performance Plastics in 2005, the company is recognized for its expertise in platinum-cured silicone technology. Its products are essential for fluid transfer applications in sterile environments, such as vaccine production, cell culture, and bioprocessing. The company's offerings are designed to meet stringent regulatory standards, including USP Class VI and FDA requirements. Today, Amesil operates as a prominent brand within Saint-Gobain's Life Sciences division, continuing to provide critical fluid handling solutions to global healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amesil.